GeezerVison is showing nanoporetech.com — Welcome to Oxford Nanopore Technologies
A clearer view
of biology
We empower people to explore and answer biological questions with our transformative sensing technology.
By enabling biological insights, we strive to improve life on earth, and beyond.
125+
Countries have adopted
20,000+
Peer-reviewed publications
28
Industry-leading partners
What you're missing
matters
Our technology is transforming how biological analysis is performed, opening new possibilities and driving meaningful impact for science, health, and society.
Ask more of
your sequencing
When your questions demand more, your sequencing should deliver more.
Richer insights
Let a multiomic view lead you to your next big discovery. Explore genomic, epigenomic, and transcriptomic variation in one go to be sure you’re seeing the full picture.
Faster results
When time is the enemy, real-time sequencing is your ultimate advantage. Let rapid insights help you make the crucial decisions that ensure every experiment runs with confidence.
Accessible technology
Whether you’re looking at a single sample or scaling to thousands, sequence on your own terms — let plug-and-play devices and intuitive workflows help you to stay focused on the research, not the setup.
One platform
Streamline the search for answers on a single technology that replaces multiple assays. Power deeper discovery with greater efficiency as you bring speed, clarity, and richer insight to your research challenge.
PromethION 24
Multiply your insights with the production-scale nanopore sequencer that shines in large-genome applications.
A trusted partner
Don’t just take it from us… leading clinicians and scientists across industries
are uncovering groundbreaking new insight in health and disease using nanopore technology.
Testimonials
We've been able to identify thousands of novel transcripts that we would have missed with short reads.
%3Aquality(80))
Kimberley Billingsley
Staff Scientist,
NIH CARD
In a single day — say, in 6.5 hours — we are able to provide actionable results to the clinicians in our hospital.
%3Aquality(80))
Adela Alcolea-Medina
Consultant Clinical Scientist,
Synnovis and GSTT
We're able to capture all these different layers of information that allows you to look at the data with nuance.
%3Aquality(80))
André Reis
Genomics Researcher,
Garvan Institute of Medical Research
%3Aquality(80))
%3Aquality(80))
%3Aquality(80))
%3Aquality(80))
%3Aquality(80))
%3Aquality(80))
%3Aquality(80))
%3Aquality(80))
%3Aquality(80))
%3Aquality(80))
%3Aquality(80))
%3Aquality(80))